FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease
Even in a pandemic, child vision tests are crucial
31 March 2021The secret to good health is no secret. So why is it so hard to achieve?
31 March 2021FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease
In 2014, two years after her Nobel Prize-winning invention of CRISPR-Cas9 genome editing, Jennifer Doudna thought the technology was mature enough to tackle a cure for a devastating hereditary disorder, sickle cell disease, that afflicts millions of people around the world, most of them of African descent. Some 100,000 Black people in the U.S. are afflicted with the disease.
